Disease / condition
Renal Impairment clinical trials
Free access to 127 studies·10+ countries·Updated daily21 recruiting
127
Total trials
10+
Countries
10+
Sponsors
21
Recruiting
By phase
Phase 1116
N/A5
Phase 43
Phase 22
Early Phase 11
By status
Completed82
Recruiting21
Not yet recruit...11
Terminated10
Enrolling by in...2
Top countries
United States of America65
Germany14
China6
New Zealand,United States of America2
Canada2
Top sponsors
Novartis Pharmaceu...12
Pfizer10
AstraZeneca5
Sanofi4
Merck Sharp & Dohm...4
Recent trials
Latest clinical trials for Renal Impairment
NCT06407375·Phase 1Recruiting
Assessment of Renal Function by Multiparametric MRI
University of ZurichSwitzerland
NCT06397872·Phase 1Enrolling by...
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function
Madrigal Pharmaceuticals, Inc.United States of America
NCT06318676·Phase 1Not yet recr...
A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment
CelgeneUnited States of America
NCT06295796·Phase 1Not yet recr...
A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)
Merck Sharp & Dohme LLC
NCT06037031·Phase 1Recruiting
A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function
PfizerUnited States of America
NCT05940402·Phase 1Recruiting
A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function
Cerevel Therapeutics, LLCUnited States of America
NCT05947097·Phase 1Recruiting
A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment
Haisco Pharmaceutical Group Co...China
NCT05927415·Phase 1Not yet recr...
A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
argenx
NCT05916573·Phase 1Completed
A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment
Haisco Pharmaceutical Group Co...China
NCT05878704·Phase 1Recruiting
Study of GBT021601 in Participants With Renal Impairment
PfizerUnited States of America
NCT05865171·Phase 1Recruiting
A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment
Vertex Pharmaceuticals Incorpo...United States of America
NCT05844228·Phase 1Not yet recr...
A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
Vir Biotechnology, Inc.United States of America
NCT05793450·Phase 1Recruiting
Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
Innovent Biologics (Suzhou) Co...China
NCT05673603·Phase 1Completed
A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment
Insmed IncorporatedUnited States of America
NCT05711381·Phase 1Recruiting
Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function
Hanmi Pharmaceutical Company L...United States of America
NCT05631938·Phase 1Recruiting
Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
Achieve Life SciencesPortugal,Spain
NCT05556135Not yet recr...
Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease
Assiut University
NCT05541159·Phase 1Not yet recr...
Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants
Novartis Pharmaceuticals
NCT05515458·Phase 1Not yet recr...
Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
Chipscreen Biosciences, Ltd.
NCT05497297·Phase 1Recruiting
A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment
Haisco Pharmaceutical Group Co...China
About this record
Access comprehensive clinical trial information for Renal Impairment through Pure Global AI's free database. This collection includes 127 clinical trials across multiple phases including Phase 1, N/A, Phase 4. Currently, 21 trials are actively recruiting participants.
Research for Renal Impairment is being conducted in United States of America, Germany, China and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 127 clinical trials studying Renal Impairment, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Pfizer, AstraZeneca, among others.